Dimed S.A. Distribuidora de Medicamentos reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was BRL 901.55 million compared to BRL 752.34 million a year ago. Net income was BRL 20.61 million compared to BRL 20.28 million a year ago. Basic earnings per share from continuing operations was BRL 0.14. Diluted earnings per share from continuing operations was BRL 0.14.